Traders bought shares of Colgate-Palmolive (NYSE:CL) on weakness during trading on Tuesday. $38.78 million flowed into the stock on the tick-up and $20.20 million flowed out of the stock on the tick-down, for a money net flow of $18.58 million into the stock. Of all equities tracked, Colgate-Palmolive had the 27th highest net in-flow for the day. Colgate-Palmolive traded down ($0.37) for the day and closed at $69.69
Several equities analysts recently weighed in on CL shares. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Societe Generale cut Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price objective for the company. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Deutsche Bank started coverage on Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price objective for the company. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a report on Tuesday, December 19th. Finally, Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Tuesday, December 19th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $77.71.
The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36. The stock has a market cap of $60,940.25, a price-to-earnings ratio of 30.57, a P/E/G ratio of 2.58 and a beta of 0.79.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be paid a $0.42 dividend. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a dividend yield of 2.41%. The ex-dividend date is Thursday, April 19th. Colgate-Palmolive’s dividend payout ratio is currently 70.18%.
In other news, Vice Chairman Franck J. Moison sold 142,979 shares of the company’s stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $70.09, for a total value of $10,021,398.11. Following the sale, the insider now directly owns 224,027 shares in the company, valued at approximately $15,702,052.43. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jennifer Daniels sold 902 shares of the company’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the completion of the sale, the insider now owns 37,788 shares in the company, valued at $2,865,086.16. The disclosure for this sale can be found here. Over the last quarter, insiders sold 455,707 shares of company stock worth $32,443,427. Corporate insiders own 1.02% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. Jacobi Capital Management LLC grew its position in Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after acquiring an additional 803 shares during the last quarter. Virtue Capital Management LLC bought a new stake in Colgate-Palmolive during the 4th quarter worth approximately $104,000. Krilogy Financial LLC grew its position in Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after acquiring an additional 289 shares during the last quarter. Calton & Associates Inc. bought a new stake in Colgate-Palmolive during the 4th quarter worth approximately $126,000. Finally, Cerebellum GP LLC bought a new stake in Colgate-Palmolive during the 4th quarter worth approximately $129,000. Institutional investors own 73.64% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Traders Buy Colgate-Palmolive (CL) on Weakness” was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://stocknewstimes.com/2018/03/20/traders-buy-colgate-palmolive-cl-on-weakness.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.